HealthCap is a specialized venture capital firm focused on life sciences, particularly innovative therapeutics companies. With offices in Stockholm and Lausanne, the firm has invested in over 125 companies since its inception in 1996. HealthCap typically participates in early to mid-stage funding rounds, with a strong presence in Series A and B investments.
Notable portfolio companies include Ultragenyx Pharmaceutical, PTC Therapeutics, and Carisma Therapeutics. HealthCap has successfully guided more than 45 companies to initial public offerings, demonstrating its expertise in nurturing and scaling life sciences startups. With approximately €1 billion in total assets, the firm offers significant financial backing and industry-specific knowledge to its portfolio companies.
HealthCap - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments34
Current Portfolio Count16
Total Portfolio Exits1
Top Investment Stages
Series A12 (40.0%)
Series B11 (36.7%)
Series C3 (10.0%)
Series D2 (6.7%)
Series E2 (6.7%)
Stage Mix
Series A 40%Series B 37%Series C 10%Series D 7%Series E 7%
Concentration shown as share of disclosed investments by stage.
HealthCap - Classification
- Also Known As
- Healthcap AB
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end